These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1579577)
1. Effect of 24,25-dihydroxyvitamin D3 in osteoclasts. Matsumoto T; Yamato H; Okazaki R; Kumegawa M; Ogata E Proc Soc Exp Biol Med; 1992 Jun; 200(2):161-4. PubMed ID: 1579577 [TBL] [Abstract][Full Text] [Related]
2. Effect of 24R,25-dihydroxyvitamin D3 on the formation and function of osteoclastic cells. Yamato H; Okazaki R; Ishii T; Ogata E; Sato T; Kumegawa M; Akaogi K; Taniguchi N; Matsumoto T Calcif Tissue Int; 1993 Mar; 52(3):255-60. PubMed ID: 8481842 [TBL] [Abstract][Full Text] [Related]
3. Effects on cultured neonatal mouse calvaria of 1 alpha,25-dihydroxyvitamin D3, 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,26,26,27,27,27-hexafluoro-1 alpha,23S,25-trihydroxyvitamin D3. Harada M; Miyahara T; Miyata M; Tomita I; Okayachi H; Ikemoto Y; Higuchi S; Otomo S; Kozuka H; Ikekawa N Bone Miner; 1992 Jul; 18(1):41-9. PubMed ID: 1422297 [TBL] [Abstract][Full Text] [Related]
4. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro. Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132 [TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3. van Leeuwen JP; Birkenhäger JC; Bos MP; van der Bemd GJ; Herrmann-Erlee MP; Pols HA J Bone Miner Res; 1992 Mar; 7(3):303-9. PubMed ID: 1585831 [TBL] [Abstract][Full Text] [Related]
6. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2. Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Chihara K J Bone Miner Res; 1997 May; 12(5):734-41. PubMed ID: 9144339 [TBL] [Abstract][Full Text] [Related]
7. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I. Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788 [TBL] [Abstract][Full Text] [Related]
8. The regulation of osteoclastic development and function. Chambers TJ Ciba Found Symp; 1988; 136():92-107. PubMed ID: 3068019 [TBL] [Abstract][Full Text] [Related]
9. Calcium regulating activity of 26,27-dimethyl analog of 24R,25-dihydroxyvitamin D3. Miyahara T; Harada M; Kondo S; Komiyama H; Matsuda S; Miyanishi A; Matsumoto M; Xue-Ya W; Ikemoto Y; Sugure A Calcif Tissue Int; 1994 Sep; 55(3):190-7. PubMed ID: 7987732 [TBL] [Abstract][Full Text] [Related]
10. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Takahashi N; Yamana H; Yoshiki S; Roodman GD; Mundy GR; Jones SJ; Boyde A; Suda T Endocrinology; 1988 Apr; 122(4):1373-82. PubMed ID: 3345718 [TBL] [Abstract][Full Text] [Related]
11. 24,25-dihydroxyvitamin D3 suppresses the rapid actions of 1, 25-dihydroxyvitamin D3 and parathyroid hormone on calcium transport in chick intestine. Nemere I J Bone Miner Res; 1999 Sep; 14(9):1543-9. PubMed ID: 10469282 [TBL] [Abstract][Full Text] [Related]
12. Induction of osteoclast formation by parathyroid hormone depends on an action on stromal cells. Fuller K; Owens JM; Chambers TJ J Endocrinol; 1998 Sep; 158(3):341-50. PubMed ID: 9846163 [TBL] [Abstract][Full Text] [Related]
13. 1 alpha,25-Dihydroxyvitamin D3[1 alpha,25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cells. Ishizuka S; Kurihara N; Hakeda S; Maeda N; Ikeda K; Kumegawa M; Norman AW Endocrinology; 1988 Aug; 123(2):781-6. PubMed ID: 3396507 [TBL] [Abstract][Full Text] [Related]
14. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402 [TBL] [Abstract][Full Text] [Related]
15. 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH) -sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action. Klem KH; Jablonski G; Saether O; Jarosz G; Gautvik KM; Gordeladze JO Biochim Biophys Acta; 1990 Sep; 1054(3):304-10. PubMed ID: 2169895 [TBL] [Abstract][Full Text] [Related]
16. 24R,25-dihydroxyvitamin D3 promotes bone formation without causing excessive resorption in hypophosphatemic mice. Ono T; Tanaka H; Yamate T; Nagai Y; Nakamura T; Seino Y Endocrinology; 1996 Jun; 137(6):2633-7. PubMed ID: 8641218 [TBL] [Abstract][Full Text] [Related]
17. Effect of stem cell factor, interleukin-6, nitric oxide and transforming growth factor-beta on the osteoclast differentiation induced by 1 alpha,25-(OH)2D3 in primary murine bone marrow cultures. Chae HJ; Park RK; Kang JS; Shin HS; Kim SC; Chung HT; Son DW; Ko KI; Kim JB; Park YC; Kim HR Pharmacol Toxicol; 1998 May; 82(5):223-9. PubMed ID: 9646327 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3. Linkhart TA; Keffer MJ Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170 [TBL] [Abstract][Full Text] [Related]
19. The effects of parathyroid hormone or 1,25-dihydroxyvitamin D3 on monocyte-osteoclast fusion. Teti A; Volleth G; Carano A; Zambonin Zallone A Calcif Tissue Int; 1988 May; 42(5):302-8. PubMed ID: 3135098 [TBL] [Abstract][Full Text] [Related]